Bacterial toxins as tools for mucosal vaccination

被引:23
作者
Mrsny, RJ
Daugherty, AL
McKee, ML
FitzGerald, DJ
机构
[1] Cardiff Univ, Welsh Sch Pharm, Ctr Drug Delivery Biol, Cardiff CF10 3XF, S Glam, Wales
[2] NCI, Div Basic Sci, Lab Mol Biol, Biotherapy Sect NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1016/S1359-6446(01)02139-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Several studies have demonstrated that the biological properties of secreted bacterial toxins could be harnessed for the induction of mucosal and systemic immunity following application at epithelial surfaces. Although the properties and potential application of several of these toxins will be discussed in this review, special focus will be placed on Pseudomonas aeruginosa exotoxin A (PE). A non-toxic form of PE (ntPE) into which antigenic epitopes can be integrated appears to be a particularly promising vaccination tool, which is able to cross the polarized epithelia of the gastrointestinal, respiratory and reproductive tracts and selectively target macrophages and dendritic cells.
引用
收藏
页码:247 / 258
页数:12
相关论文
共 81 条
[21]  
De Haan L, 1999, IMMUNOLOGY, V97, P706
[22]   Molecular aspects of medicine - A review journal for physicians and biomedical scientists [J].
Del Giudice, G ;
Pizza, M ;
Rappuoli, R .
MOLECULAR ASPECTS OF MEDICINE, 1998, 19 (01) :1-+
[23]   Genetically derived toxoids for use as vaccines and adjuvants [J].
Del Giudice, G ;
Rappuoli, R .
VACCINE, 1999, 17 :S44-S52
[24]   TARGETED DELIVERY OF PEPTIDE EPITOPES TO CLASS-I MAJOR HISTOCOMPATIBILITY MOLECULES BY A MODIFIED PSEUDOMONAS EXOTOXIN [J].
DONNELLY, JJ ;
ULMER, JB ;
HAWE, LA ;
FRIEDMAN, A ;
SHI, XP ;
LEANDER, KR ;
SHIVER, JW ;
OLIFF, AI ;
MARTINEZ, D ;
MONTGOMERY, D ;
LIU, MA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (08) :3530-3534
[25]   Genetically detoxified mutants of heat-labile toxin from Escherichia coli are able to act as oral adjuvants [J].
Douce, G ;
Giannelli, V ;
Pizza, M ;
Lewis, D ;
Everest, P ;
Rappuoli, R ;
Dougan, G .
INFECTION AND IMMUNITY, 1999, 67 (09) :4400-4406
[26]  
Dubois A, 1998, INFECT IMMUN, V66, P4340
[27]   Iscom and iscom-matrix enhance by intranasal route the IgA responses to OVA and rCTB in local and remote mucosal secretions [J].
Ekström, J ;
Hu, KF ;
Bengtsson, KL ;
Morein, B .
VACCINE, 1999, 17 (20-21) :2690-2701
[28]   Targeting of shiga toxin B-subunit to retrograde transport route in association with detergent-resistant membranes [J].
Falguières, T ;
Mallard, F ;
Baron, C ;
Hanau, D ;
Lingwood, C ;
Goud, B ;
Salamero, J ;
Johannes, L .
MOLECULAR BIOLOGY OF THE CELL, 2001, 12 (08) :2453-2468
[29]  
Fayolle C, 1999, J IMMUNOL, V162, P4157
[30]   Exploitation of mammalian host cell functions by bacterial pathogens [J].
Finlay, BB ;
Cossart, P .
SCIENCE, 1997, 276 (5313) :718-725